STOCK TITAN

GE HealthCare Technologies Inc. - GEHC STOCK NEWS

Welcome to our dedicated page for GE HealthCare Technologies news (Ticker: GEHC), a resource for investors and traders seeking the latest updates and insights on GE HealthCare Technologies stock.

GE HealthCare Technologies Inc. (NYSE: GEHC) is a leading global innovator in medical technology, pharmaceutical diagnostics, and digital solutions. The company operates through four main segments: Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Of these, the Imaging segment generates the majority of the company’s revenue.

GE HealthCare is dedicated to providing transformational medical technologies and services that enhance access to quality, affordable healthcare worldwide. Through its cutting-edge products and comprehensive solutions, the company aims to improve patient outcomes and streamline healthcare delivery.

Recent achievements include advancements in artificial intelligence (AI) integration within medical imaging, which supports more accurate and efficient diagnostics. The company is also involved in numerous partnerships with healthcare providers and research institutions to drive innovation and improve global healthcare standards.

Financially, GE HealthCare has showcased robust performance, with steady revenue growth and strong market presence. The company continuously invests in R&D to maintain its edge in the competitive healthcare industry. Their suite of products includes advanced imaging machines, ultrasound devices, patient monitoring systems, and contrast media for diagnostic imaging.

As part of a highly regulated industry, GE HealthCare adheres to strict compliance standards and maintains rigorous quality controls across its operations. The company actively engages with its community, although it reserves the right to monitor and manage public interactions to uphold professional and constructive discourse.

Rhea-AI Summary

GE HealthCare (GEHC) and Amazon Web Services (AWS) have announced a strategic collaboration to develop generative AI applications for healthcare. GE HealthCare has selected AWS as its strategic cloud provider to build and implement new foundation models aimed at transforming healthcare. The collaboration will utilize AWS services like Amazon Bedrock, Amazon Q Developer, and Amazon SageMaker to accelerate the development of medical technologies and streamline clinical workflows.

The partnership aims to improve diagnostic accuracy, enhance patient outcomes, and promote equitable care. GE HealthCare plans to leverage AWS's healthcare-specific cloud services and generative AI capabilities to build transformative clinical foundation models and applications, potentially reducing application development cycles from years to months.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
AI
-
Rhea-AI Summary

GE HealthCare (Nasdaq: GEHC) has announced an agreement to acquire Intelligent Ultrasound Group's clinical AI software business for approximately $51 million. This acquisition aims to enhance GE HealthCare's ultrasound portfolio with AI-driven image analysis tools, improving workflow efficiency and ease-of-use for clinicians.

Key highlights include:

  • Integration of Intelligent Ultrasound's ScanNav Assist AI technology into GE HealthCare's ultrasound systems
  • Addition of R&D experts to drive AI-enabled innovation in Women's Health ultrasound devices
  • Support for GE HealthCare's precision care strategy to address inefficiencies and improve patient care quality

The transaction is expected to close in Q4 2024, subject to customary closing conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.81%
Tags
-
Rhea-AI Summary

GE HealthCare (Nasdaq: GEHC) will reveal its second quarter 2024 financial results on July 31, 2024, before the market opens.

The announcement will be followed by a conference call and webcast at 8:30 a.m. Eastern Time, accessible via the company's Investor Relations website.

The webcast, earnings release, and related financial documents will also be available for replay on the same platform.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.92%
Tags
Rhea-AI Summary

GE HealthCare Technologies (Nasdaq: GEHC) has announced a cash dividend of $0.03 per share for the second quarter of 2024. This dividend will be payable on August 15, 2024, to shareholders who are on record as of July 19, 2024. The announcement reflects the company’s ongoing commitment to returning value to its shareholders.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.03%
Tags
dividends
-
Rhea-AI Summary

Heart Hospital of New Mexico at Lovelace Medical Center (HHNM) and GE HealthCare have announced the installation of the first Allia Image Guided System (IGS) Pulse in the United States. The Allia IGS Pulse is designed to enhance image quality and workflow in cardiovascular disease diagnosis and treatment. This advanced system will be employed in HHNM's cardiac electrophysiology lab for procedures like cardiac ablations, catheterizations, and valve replacements. Dr. Sean Mazer emphasized the system's ability to handle patients of all sizes and improve surgical outcomes. Brian Miller, CEO of HHNM, noted the hospital's dedication to innovative heart care. Arnaud Marie of GE HealthCare highlighted the collaboration as a testament to GE's commitment to healthcare advancements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.4%
Tags
none
-
Rhea-AI Summary

GE HealthCare and MediView XR announced the world's first installation and clinical use of the OmnifyXR Interventional Suite at North Star Vascular and Interventional in Minnesota. The augmented reality-based system, which features a heads-up holographic display, aims to revolutionize interventional radiology by providing advanced imaging, 3D anatomy visualization, and remote collaboration capabilities. The system supports workflow efficiency, improved visualization, and collaborative care. The first clinical procedures using OmnifyXR were the embolization of a genicular artery and a prostate artery. OmnifyXR is currently available in the U.S. and will expand globally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.49%
Tags
none
Rhea-AI Summary

GE HealthCare (Nasdaq: GEHC) has announced key leadership changes and the realignment of its Imaging and Ultrasound segments. Roland Rott will become the president and CEO of Imaging, while Phil Rackliffe will lead Ultrasound and Image Guided Therapies (IGT). This restructuring, effective July 1, 2024, aims to enhance patient care and business performance. IGT, a $1.6 billion subsegment of Imaging, will merge with Ultrasound in Q3 2024, creating a $5.0 billion global business. Imaging, GE HealthCare’s largest segment, will focus on surgical and interventional procedures, generating over $8.9 billion in annual revenue. The new leadership is expected to drive innovation and growth, leveraging their extensive experience in healthcare and technology.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
none
-
Rhea-AI Summary

GE HealthCare has introduced new technologies at the SNMMI 2024 meeting to enhance precision and personalized medicine globally.

The additions include MINItrace Magni, a compact cyclotron for in-house PET tracer production; Omni Legend 21 cm, a versatile PET/CT scanner; and Clarify DL, a deep learning reconstruction tech for clear imaging. These innovations aim to address global healthcare disparities, especially in underserved regions where access to diagnostic imaging is

The company also highlighted its recently acquired MIM Software solutions, which support precise, connected, and efficient care across disease states. A pharmaco-economic study suggests that using a breast oncology PET tracer in diagnostics may save the US healthcare system $142M over five years.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.86%
Tags
none
-
Rhea-AI Summary

GE HealthCare's study demonstrates that adding a PET/CT scan with the [18F]FES breast oncology tracer to the standard diagnostic process for metastatic or recurrent breast cancer patients could save the US healthcare system $142M over five years. The tracer improves diagnostic accuracy for estrogen receptor (ER) status, especially when biopsy samples are unobtainable or risky, reducing the need for repeated biopsies and ineffective treatments. Published in PLOS ONE, the study shows up to an 8% increase in accurate ER status results. Cerianna, the only FDA-approved [18F]FES PET imaging agent, is now included in the NCCN Clinical Practice Guidelines for certain breast cancer cases, further supporting its clinical and economic benefits.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none
Rhea-AI Summary

GE HealthCare (Nasdaq: GEHC) and Tampa General Hospital (TGH) are expanding their long-term partnership to deploy GE HealthCare’s Imaging and Ultrasound technology solutions across TGH Imaging’s outpatient facilities in Florida. This collaboration aims to provide more precise and timely diagnoses, improving patient outcomes and treatment plans. TGH Imaging operates 21 locations with over 65 board-certified radiologists. Previous successful implementations include a command center with GE HealthCare’s Command Center Software and a capital refresh plan for imaging technologies. TGH Imaging was also the first in Florida to install GE HealthCare’s Omni Legend digital PET/CT system in March 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
partnership

FAQ

What does GE HealthCare Technologies Inc. do?

GE HealthCare Technologies Inc. provides transformative medical technologies, pharmaceutical diagnostics, and digital solutions to improve healthcare access and quality globally.

What are the main business segments of GE HealthCare?

The main business segments are Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx).

How does GE HealthCare generate most of its revenue?

The company generates the majority of its revenue from the Imaging segment.

What recent advancements has GE HealthCare made?

GE HealthCare has made significant advancements in AI integration within medical imaging, improving diagnostic accuracy and efficiency.

Who are GE HealthCare's partners?

The company collaborates with healthcare providers and research institutions to drive innovation and improve healthcare standards.

How does GE HealthCare ensure compliance?

GE HealthCare adheres to strict regulatory compliance standards and maintains rigorous quality controls across its operations.

What products does GE HealthCare offer?

GE HealthCare offers a range of products, including imaging machines, ultrasound devices, patient monitoring systems, and diagnostic contrast media.

What is GE HealthCare's commitment to the community?

The company engages actively with its community and strives to maintain professional and positive interactions while monitoring public posts and conversations.

How has GE HealthCare performed financially?

GE HealthCare has shown robust financial performance with steady revenue growth, supported by continuous investment in research and development.

What is GE HealthCare's mission?

GE HealthCare is committed to improving patient outcomes and making quality healthcare more accessible and affordable worldwide.

GE HealthCare Technologies Inc.

Nasdaq:GEHC

GEHC Rankings

GEHC Stock Data

36.47B
456.47M
6.93%
77.39%
2.61%
Irradiation Apparatus Manufacturing
Manufacturing
Link
United States of America
CHICAGO